- Home
- EBON vs AKTX Comparison
EBON vs AKTX Comparison
Compare EBON & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- AKTX
- Stock Information
- Founded
- EBON 2010
- AKTX N/A
- Country
- EBON China
- AKTX United States
- Employees
- EBON N/A
- AKTX N/A
- Industry
- EBON Semiconductors
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- AKTX Health Care
- Exchange
- EBON Nasdaq
- AKTX Nasdaq
- Market Cap
- EBON 27.6M
- AKTX 24.5M
- IPO Year
- EBON 2020
- AKTX N/A
- Fundamental
- Price
- EBON $4.00
- AKTX $1.10
- Analyst Decision
- EBON
- AKTX
- Analyst Count
- EBON 0
- AKTX 0
- Target Price
- EBON N/A
- AKTX N/A
- AVG Volume (30 Days)
- EBON 4.9K
- AKTX 28.7K
- Earning Date
- EBON 04-25-2025
- AKTX 05-15-2025
- Dividend Yield
- EBON N/A
- AKTX N/A
- EPS Growth
- EBON N/A
- AKTX N/A
- EPS
- EBON N/A
- AKTX N/A
- Revenue
- EBON $3,591,648.00
- AKTX N/A
- Revenue This Year
- EBON N/A
- AKTX N/A
- Revenue Next Year
- EBON N/A
- AKTX N/A
- P/E Ratio
- EBON N/A
- AKTX N/A
- Revenue Growth
- EBON N/A
- AKTX N/A
- 52 Week Low
- EBON $3.80
- AKTX $0.85
- 52 Week High
- EBON $10.94
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- EBON 37.45
- AKTX 45.26
- Support Level
- EBON $3.80
- AKTX $1.26
- Resistance Level
- EBON $4.44
- AKTX $1.28
- Average True Range (ATR)
- EBON 0.21
- AKTX 0.14
- MACD
- EBON 0.01
- AKTX -0.02
- Stochastic Oscillator
- EBON 25.03
- AKTX 21.05
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).